Emboflu is a medical device company, which manufactures an embolic liquid for the treatment of Arterio-Venous Malformations.Emboflu is headquartered in Switzerland and distributes across the world through a network of dedicated partners. We are commited in improving the treatment of vascular malformations by bringing new solutions to the Practitioner.We aim to become leaders in innovating technologies, that make a valuable difference in the pratice of physicians and ultimately,in patients' lives.
| Website | http://www.emboflu.ch |
| Revenue | $1 million |
| Employees | View employees |
| Address | 30 Rte Des Avouillons, Gland, Vaud 1196, CH |
| Phone | +41 22 354 07 10 |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Johnson & Johnson, Roche, AbbVie, Novartis, Merck & Co., Inc., Pfizer, GSK, Sanofi, AstraZeneca, Bristol Myers Squibb +47 more (view full list) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular Emboflu employee's phone or email?
Emboflu Questions
The Emboflu annual revenue was $1 million in 2026.
Emboflu is based in Gland, Vaud.
The NAICS codes for Emboflu are [33, 339].
The SIC codes for Emboflu are [38, 384].
